GlassScriptPhysician profile
Esther Chavez
NPI 1245815604
$3,921.79
in general payments reported to CMS, 2019-2025
8 companies · $441 in 2025
The $441 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $177 · 2023: $2,756 · 2024: $311 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,838 · Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,837.83 |
| Food and Beverage | $1,669.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $2,740.50 | 2021-2023 | Xeomin |
| Inspire Medical Systems, INC. | $435.72 | 2023-2025 | Inspire |
| Revance Therapeutics, INC. | $303.63 | 2025 | Daxxify |
| Novo Nordisk INC | $182.84 | 2021 | |
| Galderma Laboratories, L.P. | $178.89 | 2021-2024 | Dysport |
| Nevro Corp. | $40.08 | 2024 | Senza |
| Lilly USA, LLC | $20.52 | 2021 | |
| Phadia US INC. | $19.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.